Last week, the hemp industry in the US received a critical vote of support thanks to a banking legislator, but an advocate for the industry says there’s still a long way to go for the market.
In an interview with the Investing News Network (INN), Jonathan Miller, general counsel to the US Hemp Roundtable, a lobbying and support group for the hemp industry, said a key bill currently waiting at the US Senate will really open the doors to the entire hemp space from a banking perspective.
That’s the Secure and Fair Enforcement (SAFE) Banking Act, which the US Hemp Roundtable is currently working on lobbying at the Senate level.
On December 3, a collection of bank regulators across government levels issued new guidance confirming the legal status of the hemp market in terms of banking services.
This guidance makes it so there isn’t a need to file suspicious activity reports for bank customers conducting business in the hemp industry.
The regulators include: the board of governors of the Federal Reserve System, the Federal Deposit Insurance Corporation, the Financial Crimes Enforcement Network, the Office of the Comptroller of the Currency and the Conference of State Bank Supervisors.
Miller said this change represents a major win for the hemp industry since it opens the doors for financial institutions to not be as worried when it comes to doing business within the space.
“By putting out this guidance the financial regulators have said, ‘Don’t worry, we’re not going to audit you for simply doing business with hemp or a hemp company,'” he told INN.
The US Hemp Roundtable represents 90 companies across the US, according to Miller. The hemp advocate explained banks had been afraid of getting audited for doing business with a hemp company.
According to Miller, the farm bill makes it “perfectly clear” that hemp is not a controlled substance, which should’ve been the “marching orders” for banks and other financial institutions to normalize business with hemp companies.
Still, hemp, and more critically, hemp-derived cannabidiol products, has seen a boom in the market thanks to the removal of hemp from the federal ban on marijuana as part of the farm bill of 2018.
When asked what the chances are of the bill actually getting approved by the Senate, Miller said he is cautiously optimistic about its approval, but said the bill will be more closely looked at in 2020.
The SAFE Banking Act cleared the House of Representatives back in September; since then, it’s been a slow path for the bill at the Senate level.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).